Phagenesis is developing a device for the treatment for dysphagia, the inability to swallow safely, that often accompanies stroke or other neuro-deficit diseases. The approach is to harness the brain's own capacity for relearning functions that have been lost through brain damage (via "neuroplasticity" or "corticalremapping"). Focusing initially on the care of stroke patients as they recover in hospital (acute care), Prof Shaheen Hamdy of the University of Manchester, UK, painstakingly devised a method of delivering electrical signals from the pharynx (throat) along nerve cells directly to the relevant parts of the brain. The results of his work have been published in top peer-reviewed scientific and medical journals, including The Lancet, the Nature group of publications, and Gastroenterology.

Biotechnology

Health Care

Phagenesis Ltd

Cari Manypenny

Rebecca Oxtoby

Conor Mulrooney

Fred Edenius

Klaus Annewanter

Yasmin Wan (ACCA)

Lorena Danilescu

Emily Hostetler

Maddy Sadiq

Matthew “Buck” Weller

Steve Hilty

Satish Mistry

Roma Irvine

Stephen Halstead

The Leadership Team at Phagenesis Ltd is responsible for guiding the strategic direction and operational management of the company as it innovates in the field of dysphagia treatment. This team collaborates to oversee the development of cutting-edge therapies, ensure effective marketing strategies, and optimize business operations, all while fostering a culture of research and commitment to patient safety and recovery. Their collective expertise drives the company's mission to harness neuroplasticity for enhanced patient outcomes in acute care settings.

Leadership Team

The Therapy Development Team at Phagenesis Ltd is responsible for advancing the company's innovative device aimed at treating dysphagia through neuroplasticity. This team collaborates on clinical research, manages education programs for healthcare professionals, and oversees the execution of clinical trials to validate the device's effectiveness. They play a crucial role in ensuring that the therapy not only meets regulatory standards but also translates into real-world applications that enhance recovery outcomes for stroke patients.

Therapy Development Team

The Business Development and Sales team at Phagenesis Ltd is responsible for driving market growth and establishing strategic partnerships for the company's innovative dysphagia treatment device. They identify and engage potential clients and healthcare providers across Europe, focusing on hospitals and rehabilitation centers, while developing sales strategies to effectively communicate the value of the technology. Leveraging their expertise, the team aims to expand product adoption, enhance customer relationships, and ultimately improve patient outcomes.

Business Development and Sales

Phagenesis Ltd

Org chart

Teams

Leadership Team

Therapy Development Team

Business Development and Sales

Offices

Phagenesis Ltd

Org chart

Teams

Leadership Team

Therapy Development Team

Business Development and Sales

Offices

Related companies